# PENG: an Estimation of ED50 in Neck of Femur Fracture

> **NCT05095025** · NA · UNKNOWN · sponsor: **University College Cork** · enrollment: 50 (estimated)

## Conditions studied

- Hip Fractures
- Pain, Acute

## Interventions

- **DRUG:** Bupivacaine Hydrochloride 20ml injectate

## Key facts

- **NCT ID:** NCT05095025
- **Lead sponsor:** University College Cork
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-14
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095025, "PENG: an Estimation of ED50 in Neck of Femur Fracture". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05095025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*